ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Quince Therapeutics Inc

Quince Therapeutics Inc (QNCX)

1.745
0.015
( 0.87% )

Quince Therapeutics Inc Financial Summary

The current QNCX market cap is 79.34M. The company's latest EPS is USD -1.2498 and P/E is -1.42.

Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -11.22M-28.19M-5.86M-12.01M-14.86M
Net Income -11.15M-27.73M-5.49M-12.46M-15.03M
Year End December 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -78.89M-90.32M-52.02M-34.62M-57.29M
Net Income -76.85M-89.95M-51.66M-31.39M-56.83M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 159.29M134.83M126.52M114.48M107.09M
Total Liabilities 85.12M87.86M81.59M84.33M88.51M
Total Equity 74.18M46.97M44.93M30.15M18.58M
Year End December 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 189.47M133.23M103.91M167.9M114.48M
Total Liabilities 17.2M14.64M3.32M82.82M84.33M
Total Equity 172.26M118.59M100.59M85.08M30.15M
Quarter End Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -8.35M-17.09M-24.35M-31.9M-9.6M
Investing 8.91M3.94M11.04M21.91M10.9M
Financing 190k225k-4.78M-4.78M87k
Year End December 30 2024 20202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -50.82M-62.93M-44.04M-18.29M-31.9M
Investing -52.43M58.95M18M-5.76M21.91M
Financing 118.88M6.81M707k143k-4.78M
Market Cap 79.34M
Price to Earnings Ratio -1.42
Price to Sales Ratio 0
Price to Cash Ratio 12.96
Price to Book Ratio 2.67
Dividend Yield -

Share Statistics

Shares Outstanding 45.47M
Average Volume (1 week) 317.67k
Average Volume (1 Month) 309.71k
52 Week Change 132.67%
52 Week High 2.45
52 Week Low 0.5116
Spread (Intraday) 0.03 (1.7%)

Company Info

Company Name Quince Therapeutics Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://quincetx.com
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock